They protect tumor cells from lymphocytes by inhibiting the T-cell-mediated cytotoxicity of CD4+ and CD8+ cells in malignancies such as multiple myeloma and breast cancer metastases [15, 16]. The gene discussed is CD8A; the disease is neoplasm.